{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:09:32Z","timestamp":1761743372612},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00393-010-0655-8","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T12:01:43Z","timestamp":1275912103000},"page":"516-526","source":"Crossref","is-referenced-by-count":5,"title":["Malignome und Tumor-Nekrose-Faktor-Inhibitoren bei der juvenilen idiopathischen Arthritis"],"prefix":"10.1007","volume":"69","author":[{"given":"G.","family":"Horneff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"655_CR1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","volume":"64","author":"Askling","year":"2005","unstructured":"Askling J, Fored CM, Baecklund E et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64:1414\u20131420","journal-title":"Ann Rheum Dis"},{"key":"655_CR2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692\u2013701","journal-title":"Arthritis Rheum"},{"key":"655_CR3","first-page":"abstract","volume":"Rheum","author":"Bernatsky","year":"2009","unstructured":"Bernatsky S, Rosenberg A, Kiem GO et al (2009) Malignancy in juvenile idiopathic arthritis. Arthritis Rheum (Supple): abstract 250","journal-title":"Arthritis"},{"key":"655_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0b013e31818cf555","volume":"48","author":"Cucchiara","year":"2009","unstructured":"Cucchiara S, Escher JC, Hildebrand H et al (2009) Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies? J Pediatr Gastroenterol Nutr 48:257\u2013267","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"655_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.78.4.367","volume":"78","author":"Falcini","year":"1998","unstructured":"Falcini F, Bardare M, Cimaz R et al (1998) Arthritis as a presenting feature of non-Hodgkin\u2019s lymphoma. Arch Dis Child 78:367\u2013370","journal-title":"Arch Dis Child"},{"key":"655_CR6","first-page":"366","volume":"25","author":"Flat\u00f8","year":"1998","unstructured":"Flat\u00f8 B, Aasland A, Vinje O, F\u00f8rre O (1998) Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 25:366\u2013375","journal-title":"J Rheumatol"},{"key":"655_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.2005.044784","volume":"65","author":"Franklin","year":"2006","unstructured":"Franklin J, Lunt M, Bunn D et al (2006) Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis. Ann Rheum Dis 65:617\u2013622","journal-title":"Ann Rheum Dis"},{"key":"655_CR8","unstructured":"GEKID (2008) Cancer in Germany, 6th edn. http:\/\/www.ekr.med.uni-erlangen.de\/GEKID\/Doc\/kid2008_english.pdf"},{"key":"655_CR9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.\u2013U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children\u2019s Study Group. N Engl J Med 326:1043\u20131049","journal-title":"N Engl J Med"},{"key":"655_CR10","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","volume":"60","author":"Giannini","year":"2009","unstructured":"Giannini EH, Ilowite NT, Lovell DJ et al (2009) Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 60:2794\u20132804","journal-title":"Arthritis Rheum"},{"key":"655_CR11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2008.096925","volume":"69","author":"Hellgren","year":"2010","unstructured":"Hellgren K, Iliadou A, Rosenquist R et al (2010) Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study. Ann Rheum Dis 69:654\u2013659","journal-title":"Ann Rheum Dis"},{"key":"655_CR12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"Horneff","year":"2009","unstructured":"Horneff G, De Bock F, Foeldvari I et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA). Preliminary data from the German JIA Registry. Ann Rheum Dis 68:519\u2013525","journal-title":"Ann Rheum Dis"},{"key":"655_CR13","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T et al (2004) The German Etanercept Registry for treatment of juvenile idiopathic arthritis (JIA). Ann Rheum Dis 63:1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"655_CR14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00393-005-0002-7","volume":"65","author":"Horneff","year":"2006","unstructured":"Horneff G (2006) Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Worlitzer Expertengesprache 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie. Z Rheumatol 65:152\u2013156, 158","journal-title":"Z Rheumatol"},{"key":"655_CR15","first-page":"326","volume":"31","author":"Horneff","year":"2008","unstructured":"Horneff G (2008) Medical treatment of juvenile idiopathic arthritis. Med Monatsschr Pharm 31:326\u2013336","journal-title":"Med Monatsschr Pharm"},{"key":"655_CR16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00393-008-0426-y","volume":"68","author":"Hospach","year":"2009","unstructured":"Hospach T, Haas JP, Huppertz HI et al (2009) Stellungnahme der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie zur Meldung der US-Food and Drug Administration (FDA) \u00fcber F\u00e4lle von Malignomen bei Anti-TNF-behandelten Patienten. Z Rheumatol 68:162\u2013164","journal-title":"Z Rheumatol"},{"key":"655_CR17","first-page":"1681","volume":"35","author":"Imundo","year":"2008","unstructured":"Imundo L (2008) Hodgkin\u2019s lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: supplemental case report. J Rheumatol 35:1681","journal-title":"J Rheumatol"},{"key":"655_CR18","unstructured":"Kaatsch P (2008) Jahresbericht Kinderkrebsregister. http:\/\/www.kinderkrebsregister.de"},{"key":"655_CR19","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1517\/14656560903386300","volume":"10","author":"Klein","year":"2009","unstructured":"Klein A, Horneff G (2009) Treatment strategies for juvenile idiopathic arthritis. Expert Opin Pharmacother 10:3049\u20133060","journal-title":"Expert Opin Pharmacother"},{"key":"655_CR20","first-page":"118","volume":"13","author":"Kvien","year":"1986","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B (1986) Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 13:118\u2013123","journal-title":"J Rheumatol"},{"key":"655_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.critrevonc.2005.02.004","volume":"56","author":"Kwon","year":"2005","unstructured":"Kwon JH, Farrell RJ (2005) The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol 56:169\u2013178","journal-title":"Crit Rev Oncol Hematol"},{"key":"655_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763\u2013769","journal-title":"N Engl J Med"},{"key":"655_CR23","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","volume":"54","author":"Lovell","year":"2006","unstructured":"Lovell DJ, Reiff A, Jones OY et al (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 54:1987\u20131994","journal-title":"Arthritis Rheum"},{"key":"655_CR24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S et al (2008) Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359:810\u2013820","journal-title":"N Engl J Med"},{"key":"655_CR25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e3181957a11","volume":"48","author":"Mackey","year":"2009","unstructured":"Mackey AC, Green L, Leptak C, Avigan M (2009) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr 48:386\u2013388","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"655_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","volume":"44","author":"Mackey","year":"2007","unstructured":"Mackey AC, Green L, Liang LC et al (2007) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44:265\u2013267","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"655_CR27","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392\u20132401","journal-title":"Arthritis Rheum"},{"key":"655_CR28","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2003.008516","volume":"63","author":"Minden","year":"2004","unstructured":"Minden K, Niewerth M, Listing J et al (2004) Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 63:836\u2013842","journal-title":"Ann Rheum Dis"},{"key":"655_CR29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","volume":"44","author":"Navarro","year":"2003","unstructured":"Navarro JT, Ribera JM, Mate JL et al (2003) Hepatosplenic T-gammadelta lymphoma in a patient with Crohn\u2019s disease treated with azathioprine. Leuk Lymphoma 44:531\u2013533","journal-title":"Leuk Lymphoma"},{"key":"655_CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/rheumatology\/38.8.739","volume":"38","author":"Petty","year":"1999","unstructured":"Petty RE (1999) Prognosis in children with rheumatic diseases: justification for consideration of new therapies. Rheumatology 38:739\u2013742","journal-title":"Rheumatology"},{"key":"655_CR31","first-page":"31","volume":"58","author":"Pontikaki","year":"2006","unstructured":"Pontikaki I, Gerloni V, Gattinara M et al (2006) Side effects of anti-TNF alpha therapy in juvenile idiopathic arthritis. Reumatismo 58:31\u201338","journal-title":"Reumatismo"},{"key":"655_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.2007.087411","volume":"68","author":"Prince","year":"2008","unstructured":"Prince FH, Twilt M, Ten Cate R et al (2008) Long-term follow-up on effectiveness and safety of etanercept in JIA: the Dutch National Register. Ann Rheum Dis 68:635\u2013641","journal-title":"Ann Rheum Dis"},{"key":"655_CR33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","volume":"13","author":"Rosh","year":"2007","unstructured":"Rosh JR, Gross T, Mamula P et al (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn\u2019s disease: a cautionary tale? Inflamm Bowel Dis 13:1024\u20131030","journal-title":"Inflamm Bowel Dis"},{"key":"655_CR34","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R et al (2007) Pediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group: a randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 56:3096\u20133106","journal-title":"Arthritis Rheum"},{"key":"655_CR35","first-page":"599","volume":"5","author":"Ruperto","year":"2006","unstructured":"Ruperto N, Ravelli A, Castell E et al (2006) Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG\/PRINTO phase IV post marketing surveillance study. Clin Exp Rheumatol 5:599\u2013605","journal-title":"Clin Exp Rheumatol"},{"key":"655_CR36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"Sandlund","year":"1996","unstructured":"Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin\u2019s lymphoma in childhood. N Engl J Med 334:1238\u20131248","journal-title":"N Engl J Med"},{"key":"655_CR37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","volume":"352","author":"Silverman","year":"2005","unstructured":"Silverman E, Mouy R, Spiegel L et al (2005) Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med 352:1655\u20131666","journal-title":"N Engl J Med"},{"key":"655_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, MacFarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497\u2013502","journal-title":"Int J Cancer"},{"key":"655_CR39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/sarh.2000.5752","volume":"29","author":"Trapani","year":"2000","unstructured":"Trapani S, Grisolia F, Simonini G et al (2000) Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum 29:348\u2013359","journal-title":"Semin Arthritis Rheum"},{"key":"655_CR40","unstructured":"U.S. Food and Drug Administration (2008) Early communication about an ongoing safety review of tumor necrosis factor (TNF) blockers (marketed as Remicade, Enbrel, Humira, and Cimzia). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm070725.htm"},{"key":"655_CR41","unstructured":"U.S. Food and Drug Administration (2009) Information for Healthcare Professionals: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174474.htm"},{"key":"655_CR42","unstructured":"U.S. Food and Drug Administration (2009b) Questions and Answers \u2013 TNF Blockers 8\/25\/2009. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm180694.htm"},{"key":"655_CR43","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","volume":"56","author":"Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56:2886\u20132895","journal-title":"Arthritis Rheum"},{"key":"655_CR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(05)60640-X","volume":"351","author":"Woo","year":"1998","unstructured":"Woo P, Wedderburn LR (1998) Juvenile chronic arthritis. Lancet 351:969\u2013973","journal-title":"Lancet"},{"key":"655_CR45","first-page":"1680","volume":"35","author":"Yildirim-Toruner","year":"2008","unstructured":"Yildirim-Toruner C, Kimura Y, Rabinovich E (2008) Hodgkin\u2019s lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. J Rheumatol 35:1680\u20131681","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0655-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-010-0655-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0655-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:02Z","timestamp":1559061362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-010-0655-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s00393-010-0655-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}